Matthew Havrda retweeted
Molecular & Systems Biology at the Geisel School of Medicine at Dartmouth is excited to recruit an Assistant Professor to our department. Find information on the breadth of our search and our commitment to faculty diversity at geiselmed.dartmouth.edu/msb/… @GeiselMed @Dartmouth
Matthew Havrda retweeted
New paper alert! Awesome work from PhD student @SeqWithSteve with @lsalas_epigenet and @MatthewHavrda. Way to go Steve! @DartmouthNeuro @DartmouthHealth @GeiselMed
Very excited to share our recent work where we identify #Parkinsons related blood immune profiles and detect them in prodromal patients, before the onset of their motor symptoms nature.com/articles/s41531-0… @lsalas_epigenet @francesca_gilli @ZeZhang0223 @MatthewHavrda @SpringerNature
Matthew Havrda retweeted
Help us change the #FutureOfPD 🤝 Sign up for a #MovingDayWalk near you today and start raising funds and awareness for Parkinson’s disease: MovingDayWalk.org
Matthew Havrda retweeted
Awesome presentation on the role of PP2A in Wnt signaling by @NawatBunnag at Europhosphatases 2023 in Copenhagen @MCBDartmouth
Matthew Havrda retweeted
I am featured in this article commenting on how #ApoE4 genotype status and sex seem to impact the benefit and risk of #Leqembi treatment.
The future of treating #Alzheimers disease is developing a personalized medicine approach to care - incorporating factors like sex, genetics, and more, into one’s treatment regimen. Anti-amyloid antibody drugs are a start to this future becoming a reality. While they are certainly not a cure for Alzheimer’s disease, they can be thought of as an important addition to a tool belt, that will hopefully one day be full of a number of different drugs, that will work in tandem, in unique combinations, to fight Alzheimer’s disease. A one size fits all approach can and should not be the goal.
Great explanatory article by @AmandaKrupa !
The @US_FDA has approved a drug to slow the progression of #Alzheimers disease. Here’s a look at what’s known about #Leqembi and what lies ahead in the fight against Alzheimer’s disease. care.com/c/what-is-the-new-d…
Matthew Havrda retweeted
📢 And our final kudos to @bdemiranda, 2023 Stanley Fahn Awardee (and former Postdoc Awardee!) who will be looking at how environmental exposures accelerate senescence and influence #Parkinsons neurodegeneration @UABNews.
@ParkinsonDotOrg
Matthew Havrda retweeted
📢 Congratulations are in order for 2023 Postdoctoral Fellowship Awardee @tahneesaunders 🇦🇺, who will be restraining mitochondrial damage-induced inflammation to treat #Parkinsons disease @WEHI_research
@ParkinsonDotOrg
Matthew Havrda retweeted
Can you help us #ReachFurther? The Parkinson’s Foundation Reach Further campaign will invest an additional $30 million to accelerate progress on Parkinson’s disease research, improve care and increase access to quality-of-life programs. 💙 🩺
Learn more: youtu.be/-XJNWuU3wSA
Matthew Havrda retweeted
Communication is multi-modal, including both speech & gesture. Many patients with left hemisphere stroke have impairments in both domains. Research in the Cognition & Action Lab at @MossResearch is helping us understand how gesture impairment (limb apraxia) impacts communication.
Rising stars on display @dartmouth Wetterhahn undergraduate advising and research symposium.
Matthew Havrda retweeted
Did you know that the Parkinson's Foundation has resources specifically for Veterans with Parkinson's disease? For Military Appreciation Month, check out our YouTube playlist for Veterans with PD and their care partners: youtube.com/playlist?list=PL…
Sunny day in Philadelphia talking #Parkinson and meeting with great scientists @NeuroatJeff @Jeff_PD_center
Matthew Havrda retweeted
🚨Looking for a Research Assistant to join our vibrant team @uOttawaBMRI @OISB_IBSO @CNMDOttawa @uOttawaMed. Please spread the word! 👩🔬👨🔬🥼🧪
jobrxiv.org/job/university-o…
Matthew Havrda retweeted
A recent study adds promising new data to bolster support for a test that may allow Parkinson’s to be diagnosed before symptoms appear and may help inform Parkinson’s clinical trials.
🩺 Learn more on our website: Parkinson.org/blog/science-n…
Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune | Movement Disorders | JAMA Neurology | JAMA Network jamanetwork.com/journals/jam…
Great week of science and fun #Parkinsons @GordonConf. Echoing a big thanks to @MaluTansey and @NelsonLabUCSF for an unforgettable meeting!
Matthew Havrda retweeted
The Halpern Lab is recruiting ! Please share ! Follow the link for a full description of this research technician opportunity and instructions on how to apply. searchjobs.dartmouth.edu/pos…
@dartmouth @GeiselMed @marnieeh @MCBDartmouth @DartmouthNeuro @QBSdartmouth @DartGRAD
Finally getting the team together in person to talk #Parkinsons with the fearless patients and caregivers in the Upper Valley! Thanks @ParkinsonDotOrg @MsbDartmouth @GeiselMed
Matthew Havrda retweeted
Dear GenZ, Writing professional emails, saying please and thank you, and demonstrating good manners is always appreciated. Showing respect demonstrates you are serious about your work and future. It also demonstrates kindness and makes me feel kinder in return. Sincerely, Laura






















